enVVeno Medical (NVNO) Short term Debt (2017 - 2020)
enVVeno Medical's quarterly Short term Debt came in at $281183.0 in Q2 2020, up 40.66% quarter-over-quarter from $199907.0 in Q1 2020.
enVVeno Medical has reported Short term Debt for 2 years, with the latest figure at $281183.0 in Q2 2020.
- For the quarter ending Q2 2020, Short term Debt changed N/A year-over-year to $281183.0; the trailing twelve-month figure through Jun 2020 stood at $281183.0 (changed N/A YoY), and the FY2017 full-year result was $3.1 million, changed N/A from the prior year.
- Short term Debt for Q2 2020 stood at $281183.0, up from $199907.0 in the prior quarter.
- The five-year high for Short term Debt was $3.1 million in Q4 2017, with the low at $199907.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 281,183.00 |
| Mar 31, 2020 | 199,907.00 |
| Dec 31, 2017 | 3.08 Mn |